Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Jan-Mar;14(1):175-180.
doi: 10.4103/ajns.AJNS_137_18.

Venture in 101 Cranial Punctures: A Comparative Study between Frame-based versus Frameless Biopsy of 101 Intracranial Space Occupying Lesion

Affiliations

Venture in 101 Cranial Punctures: A Comparative Study between Frame-based versus Frameless Biopsy of 101 Intracranial Space Occupying Lesion

Suresh Bishokarma et al. Asian J Neurosurg. 2019 Jan-Mar.

Abstract

Background: Presumptive diagnosis based solely on the clinical picture and imaging is not sufficient to provide appropriate treatment with certainty and hence histopathological confirmation of intracranial space occupying lesion (ICSOL) is essential. Needle biopsy via stereotactic frame-based or frameless neuronavigation technique is efficient procedure. The objective of this study is to compare their accuracy and efficacy and safety.

Methods: This is a retrospective comparative study conducted among 101 biopsies of ICSOL. Patients data were retrieved from medical record. Data were analyzed in SPSS ver. 20. P value of <0.05 was considered significant.

Results: Out of 101 patients, Frame-based stereotactic biopsy was done among 55 patients (54.4%) while 46 patients (45.6%) underwent frameless stealth neuronavigation guided biopsy. Male to female ration was 2.1:1. Age ranged from 5 to 82 years. 54.5% (55 patients) have deeper location of tumor while 45.5% (46 patients) have lobar location of tumor. Frontal (16.8%) and Thalamic (13.8%) were the common site. Mean size of tumor was 3.09±0.85cms. There was statistically significant difference in operative duration among study groups. Overall Diagnostic yield was 89.1%. Glioma was the most common (50.5%) diagnosis. Glioblastoma WHO Grade IV was 37.6% followed by lymphoma (12.8%).

Conclusion: Needle biopsy via stereotactic frame-based or neuronavigation frameless technique is a safe and efficient procedure having high diagnostic yield. Reasons for negative biopsy could be missed target or retrieval of gliotic tissue.

Keywords: Biopsy; accuracy; brain lesion; frame-based; frameless; neuronavigation.

PubMed Disclaimer

Conflict of interest statement

There are no conflicts of interest.

Figures

Figure 1
Figure 1
(a) Localizer ring secured in the outer table of the skull, (b) Patient in CT console with frame fixed on the head, (c) Rectilinear phantom pointer (RLPP) with CRW stereotactic frame calibrated to phantom target, (d) CRW frame is mounted on patient head for biopsy of target lesion
Figure 2
Figure 2
(a) Head fixed with three pins clamp on Mayfield, (b) Target lesion is navigated and locked for biopsy from shortest safe route, (c) Burr hole and durostomy before biopsy, (d) Delivering Biopsy specimen for Histopathological examination

References

    1. Conway LW. Stereotaxic diagnosis and treatment of intracranial tumors including an initial experience with cryosurgery for pinealomas. J Neurosurg. 1973;38:453–60. - PubMed
    1. Bernstein M, Parrent AG. Complications of CT-guided stereotactic biopsy of intra-axial brain lesions. J Neurosurg. 1994;81:165–8. - PubMed
    1. Dorward NL, Paleologos TS, Alberti O, Thomas DG. The advantages of frameless stereotactic biopsy over frame-based biopsy. Br J Neurosurg. 2002;16:110–8. - PubMed
    1. Horsly V, Clarke RH. The structure and function of cerebellum examined by a new method. Brain. 1908;31:45–124.
    1. Quiñones-Molina R, Alaminos A, Molina H, Muñoz J, López G, Alvarez L, et al. Computer-assisted CT-guided stereotactic biopsy and brachytherapy of brain tumors. Stereotact Funct Neurosurg. 1994;63:52–5. - PubMed